Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-21T13:09:57.808Z Has data issue: false hasContentIssue false
  • English
  • Français

Late Pseudo-Exacerbation of Myasthenia Gravis Due to Ectopic Thymoma Invading Lower Cranial Nerves

Published online by Cambridge University Press:  18 September 2015

Gregg MacLean ,
Alan Guberman  and
Antonio Giulivi
Gregg MacLean
Affiliation:
Divisions of Neurology and Hematology, University of Ottawa, Ottawa General Hospital, Ottawa
Alan Guberman*
Affiliation:
Divisions of Neurology and Hematology, University of Ottawa, Ottawa General Hospital, Ottawa
Antonio Giulivi
Affiliation:
Divisions of Neurology and Hematology, University of Ottawa, Ottawa General Hospital, Ottawa
*
Division of Neurology, University of Ottawa, Ottawa General Hospital, Ottawa, Ontario, Canada K1H 8L6
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Dysarthria, dysphagia and repeated aspiration in a 54-year-old woman diagnosed and treated for myasthenia gravis 7 years earlier were initially thought to represent a late exacerbation of myasthenia. A cervical mass invading the jugular foramen and causing multiple lower cranial nerve palsies was biopsied and found to represent invasive ectopic thymoma.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 17 , Issue 1 , February 1990 , pp. 46 - 48
Copyright
Copyright © Canadian Neurological Sciences Federation 1990

References

REFERENCES

1.Goldman, AJ, Herrmann, C, Keesey, JC, et al. Myasthenia gravis and invasive thymoma: a 20-year experience. Neurology 1975; 25: 1021–1025.CrossRefGoogle Scholar
2.Bernatz, PE, Khonsari, MA, Harrison, EG, et al. Thymoma: factors influencing prognosis. Surg Clin NA 1973; 53: 885–892.CrossRefGoogle ScholarPubMed
3.Ridenhour, CE, Henzel, GH, DeWeese, MS, et al. Thymoma arising from undescended cervical thymus. Surgery 1970; 67: 614–618.Google ScholarPubMed
4.Levine, GD, Rosai, J. Thymic hyperplasia and neoplasia: a review of current concepts. Human Pathology 1978; 9: 495–514.CrossRefGoogle ScholarPubMed
5.Monden, Y, Nakahara, K, Nanjo, S, et al. Invasive thymoma with myasthenia gravis. Cancer 1984; 54: 2513–2518.3.0.CO;2-I>CrossRefGoogle ScholarPubMed
6.Verley, JM, Holman, KH. Thymoma: a comparative study of clinical stages, histological features and survival in 200 cases. Cancer 1985; 53: 1074–1086.3.0.CO;2-T>CrossRefGoogle Scholar
7.Dangaard, G, Hansen, H, Borth, M. Combination chemotherapy for malignant thymoma. Ann Intern Med 1983; 99: 189–190.CrossRefGoogle Scholar
8.Bruno, A, Adams, HP Jr. Neurologic problems in renal transplant recipients. Neurol Clin 1988; 6: 305–325.CrossRefGoogle ScholarPubMed
9.Katz, P, Fauci, AS. Immunosuppressives and Immunoadjuvants, Chapter 25. In: Samter, M, Ed. Immunological Diseases,4th Ed., Boston: Little, Brown and Company, 1988; 1: 675–698.Google Scholar
10.Oosterhuis, HJ. Observations of the natural history of myasthenia gravis and the effect Of thymectomy. Ann NY Acad Sci 1981; 377: 678–690.CrossRefGoogle ScholarPubMed